Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Pharmacodynamics of Sugammadex Dosed by Corrected Body Weight for Reversal of Vecuronium in Obese Patients

NCT05328778 is registered in ClinicalTrials.gov with Guangzhou General Hospital of Guangzhou Military Command as lead sponsor.

NCT NCT05328778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05328778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Pharmacodynamics of Sugammadex Dosed by Corrected Body Weight for Reversal of Vecuronium in Obese Patients
Lead sponsor
Guangzhou General Hospital of Guangzhou Military Command
Phase
Phase 4
Overall status
Completed
Start date
April 14, 2022
Completion date
April 1, 2026
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics